Samsung Bioepis publishes new biosimilars white paper

Nov 17, 2021

Samsung Bioepis launched a new white paper entitled ‘Improving the Understanding and Acceptance of Biosimilars in the United States’. In particular, the paper discusses the need to reduce information gaps, incentivise different stakeholders and practical considerations for implementation.

Print Page Mail Article